Italian Registry Will Map Real-World Cardiac Rehabilitation After Heart Failure and Ischaemic Events
Italy’s ITACARE-P registry is designed to capture what happens after discharge for patients with heart failure and ischaemic heart disease who enter early post-acute cardiac rehabilitation. The protocol is built around a multicentre, prospective, observational design, with consecutive enrolment across participating centres so the dataset reflects everyday practice rather than a highly selected trial population. In a field where rehabilitation pathways are often shaped by local resources, staffing, and programme structure, that design choice matters because it captures the real variation clinicians confront at the bedside.
The registry is not trying to prove efficacy in the way a drug trial would. It is trying to measure quality, clinical change, and downstream outcomes in a structured way that can support future registry-based randomised trials.
Consecutive Enrolment Across Mixed Rehabilitation Settings
The network includes patients treated in different cardiac rehabilitation settings, among them inpatient, day-hospital, and outpatient programmes. This broad inclusion should make the registry more representative of the post-acute population seen in routine care, but it also introduces heterogeneity in rehabilitation pathways, treatment intensity, and data completeness. Those differences are not a weakness to be hidden; they are part of the clinical reality the registry is built to describe.
A single rehabilitation model rarely fits every patient recovering from acute or chronic cardiac disease. Some individuals arrive after a recent hospitalization with substantial deconditioning, others with persistent symptoms, and others with a mix of functional limitation and medication optimisation needs. By enrolling patients across multiple programme types, ITACARE-P is positioned to capture how recovery unfolds when rehabilitation is delivered under different operational constraints.
One sentence captures the clinical stakes plainly: post-acute cardiac rehabilitation does not happen in a vacuum.
Standardised Quality Indicators Anchor the Dataset
The protocol uses a predefined common dataset based on internationally established quality indicators. That choice gives the registry a standard language for comparing centres and for assessing whether care processes are being delivered consistently. In practical terms, a shared dataset reduces the risk that one hospital documents functional recovery in a different way from another, or that treatment-related variables are captured too inconsistently to support meaningful comparison.
The emphasis on standardisation is especially relevant in cardiac rehabilitation, where a programme may include exercise prescription, risk factor control, medication review, symptom surveillance, and education, yet the intensity and documentation of each component can vary widely. A registry built on common indicators can reveal where programme quality is strong, where variation is greatest, and where improvement efforts should begin. It also creates a foundation for benchmarking across centres without forcing every site into an identical care pathway.
Functional Status, Quality of Life, and Treatment Change Are All in Scope
The prospective collection of clinical, functional, quality-of-life, and treatment-related variables gives the registry a wider lens than administrative outcomes alone would allow. Changes from admission to completion of cardiac rehabilitation can be tracked directly, which is important because early post-acute recovery often involves more than a single endpoint. Patients may improve in exercise tolerance, symptom burden, mood, medication adherence, or self-management even when no event-driven endpoint is triggered.
That broader view is clinically useful. Cardiac rehabilitation is not limited to surveillance; it is a structured period during which the care team can modify therapies, reinforce risk reduction, and observe whether the patient’s status is stabilising after a recent cardiac event or the diagnosis of chronic disease. By collecting treatment-related variables alongside patient-reported and functional measures, the registry can relate what is done during rehabilitation to what changes by programme completion.
For clinicians, the likely value is straightforward: a registry like this can separate a patient who is enrolled from a patient who actually improves.
Follow-up at 6 and 12 Months Will Test Durability of Recovery
The protocol extends surveillance beyond discharge from rehabilitation with telephone follow-up at 6 and 12 months. That longer horizon is important because the early gains of rehabilitation may fade if medication adherence weakens, physical activity drops, or symptoms recur after the structured programme ends. Follow-up by phone is also a practical way to reach a broad real-world cohort without requiring every patient to return to a single central site.
Telephone collection carries its own limitations. Missing information and loss to follow-up are expected risks, and the protocol acknowledges that these data may be incomplete. In a registry study, that kind of attrition can affect the precision of outcome estimates and complicate comparisons between centres or programme types. Even so, the alternative would be to stop observation at programme completion, which would leave the durability of recovery largely unmeasured.
Why a Registry Matters in the Post-Acute Cardiac Setting
Despite recent reductions in acute-phase mortality among patients with heart disease, the burden after discharge remains substantial. Patients with heart failure or ischaemic heart disease often move from the acute hospital setting into a period where treatment adherence, exercise capacity, and functional independence determine whether recovery continues or stalls. Cardiac rehabilitation sits directly in that transition, yet its impact in routine care is often harder to quantify than in tightly controlled studies.
ITACARE-P is built to close that gap by creating a real-world framework for quality measurement and outcome tracking across the Italian early post-acute cardiac rehabilitation network. The multicentre structure should make the registry broad and representative. The common dataset should support standardisation. The repeated assessment schedule should show whether changes observed at rehabilitation discharge persist over time.
The protocol also lays groundwork for future registry-based randomised trials, which could use this infrastructure to test interventions inside a living rehabilitation network rather than building an entirely new study platform from scratch. That is a meaningful operational step, because much of rehabilitation research fails not at the level of biological plausibility but at the level of implementation, follow-up, and comparability across sites.
Heterogeneity Will Be Recorded, Not Ignored
Mixed inpatient, day-hospital, and outpatient pathways will inevitably produce variation in case mix, programme exposure, and missingness. The registry is not built to erase that variation. It is built to document it carefully enough that future investigators can understand how different care settings shape recovery trajectories and where data quality needs tightening.
In that sense, the most important limitation is also one of the registry’s defining strengths. Real-world rehabilitation is messy, and the protocol accepts that messiness as the starting point for better measurement. The next challenge will be whether the 6- and 12-month follow-up data remain complete enough to support robust comparisons across centres and rehabilitation models.